Related by context. All words. (Click for frequent words.) 73 chemoradiotherapy 72 neoadjuvant therapy 72 5FU 71 doxorubicin 71 radical nephrectomy 70 azacitidine 70 chemoradiation 70 dacarbazine 69 vinorelbine 69 gemcitabine 69 Doxil ® 69 FOLFOX4 69 nephrectomy 69 neoadjuvant chemotherapy 69 idarubicin 69 colorectal liver metastases 69 chemoembolization 69 pancreatic adenocarcinoma 69 Fludara 68 hepatic metastases 68 CsA 68 etoposide 68 decitabine 68 pegylated liposomal doxorubicin 68 bevacizumab Avastin ® 68 nab paclitaxel 68 trabectedin 68 chemoradiation therapy 68 fluorouracil 68 carboplatin paclitaxel 68 lymphadenectomy 67 EBRT 67 cisplatin 67 DAPT 67 mycophenolate mofetil 67 cytotoxic chemotherapy 67 external beam radiotherapy 67 radiofrequency ablation RFA 67 5-FU/LV 67 imatinib 67 cystectomy 67 preoperative chemotherapy 67 cytoreductive surgery 67 sorafenib Nexavar 67 docetaxel chemotherapy 67 zoledronic acid 67 sunitinib 67 FOLFIRI 67 radiochemotherapy 67 transurethral resection 67 heavily pretreated patients 67 bortezomib 67 chlorambucil 67 trastuzumab 67 metastatic malignant 67 alkylating agent 66 epirubicin 66 HER2 positive metastatic breast 66 daunorubicin 66 recurrent glioblastoma multiforme 66 ALND 66 ASCT 66 gemcitabine Gemzar 66 neoadjuvant 66 temsirolimus 66 cytoreduction 66 Irinotecan 66 chemotherapy docetaxel 66 peritoneal carcinomatosis 66 concurrent chemoradiation 66 chemotherapeutic regimens 66 metastatic renal cell carcinoma 66 topotecan 66 chemotherapeutic agents 66 imatinib Gleevec 66 mitoxantrone 66 fulvestrant 66 fibrinolysis 66 azacytidine 66 metastatic RCC 66 postoperative chemotherapy 66 imatinib therapy 66 CHOP chemotherapy 66 unresectable 66 bleomycin 66 interferon alfa 66 gefitinib Iressa 66 resectable 66 GnRH agonists 66 liver resection 66 FOLFOX 66 pCR 65 relapsed ovarian cancer 65 idraparinux 65 estramustine 65 mRCC 65 CA4P 65 radical cystectomy 65 cytoreductive nephrectomy 65 Doxorubicin 65 MGd 65 OPCAB 65 bevacizumab Avastin 65 ABVD 65 liposomal doxorubicin 65 gemcitabine cisplatin 65 standard chemotherapy regimen 65 NMIBC 65 leukemia AML 65 taxane chemotherapy 65 interferon alfa 2a 65 Fludarabine 65 intravesical 65 IFN α 65 temozolomide 65 vorinostat 65 DFMO 65 Trastuzumab 65 intravesical therapy 65 irinotecan chemotherapy 65 Gliadel Wafer 65 prostate carcinoma 65 pertuzumab 65 liver metastases 65 DMARD 65 recurrent GBM 65 fallopian tube carcinoma 65 β blockers 65 TURP 65 bevacizumab 65 oblimersen 65 ribavirin RBV 65 renal tumors 65 EGFr 65 paclitaxel 65 Cisplatin 65 pneumonectomy 65 leukemia CLL 65 LHRH agonist 64 intra arterial 64 IFN beta 64 octreotide 64 tyrosine kinase inhibitor 64 thromboembolic events 64 docetaxel 64 lymph node dissection 64 mitomycin C 64 GnRH agonist 64 erlotinib Tarceva ® 64 partial nephrectomy 64 trans retinoic acid 64 IV NSCLC 64 LMWH 64 mTOR inhibitors 64 adriamycin 64 chemotherapeutic regimen 64 locoregional 64 refractory NSCLC 64 dexamethasone Decadron 64 antithymocyte globulin 64 adjuvant therapy 64 HSCT 64 octreotide LAR 64 paroxysmal AF 64 dose cytarabine 64 stage IIIB 64 superficial bladder cancer 64 adalimumab 64 gemcitabine carboplatin 64 Surgical resection 64 standard chemotherapy regimens 64 cyclophosphamide methotrexate 64 paclitaxel eluting stents 64 vinca alkaloid 64 mitomycin 64 abciximab 64 pemetrexed 64 nonoperative 64 sorafenib Nexavar ® 64 lobectomy 64 bosentan 64 clodronate 64 Taxol ® 64 bypass grafting 64 5 Fluorouracil 64 cisplatin resistant 64 HoLEP 64 transarterial 64 gefitinib 64 dose dexamethasone 64 colorectal cancer liver metastases 64 fondaparinux 64 Mitomycin C 64 antithrombotic therapy 64 fibrinolytic 64 cetuximab Erbitux R 64 CIMZIA TM 64 refractory AML 64 lung metastases 64 transplantation HCT 64 tyrosine kinase inhibitors 64 sirolimus eluting stent 64 melphalan prednisone 64 VAPRISOL 64 cisplatin gemcitabine 63 GISTs 63 Torisel 63 locoregional recurrence 63 YONDELIS 63 receptor tyrosine kinase inhibitor 63 androgen deprivation 63 lenalidomide dexamethasone 63 tocilizumab 63 azathioprine 63 5 fluorouracil 63 bladder carcinoma 63 docetaxel Taxotere ® 63 paclitaxel carboplatin 63 xenograft models 63 antiplatelet therapy 63 prostate TURP 63 transfemoral 63 metastatic GIST 63 NovoTTF 63 trabeculectomy 63 Gemcitabine 63 iodixanol 63 allogeneic stem cell 63 bicalutamide 63 Radiofrequency ablation 63 ovarian carcinoma 63 Cytoxan 63 thoracoscopic lobectomy 63 DOXIL 63 chemoresistant 63 5 FU 63 thalidomide Thalomid 63 neointimal hyperplasia 63 APTIVUS r 63 bendamustine 63 transarterial chemoembolization 63 neoadjuvant treatment 63 cetuximab 63 fluoropyrimidine 63 EUS FNA 63 allogeneic SCT 63 Bortezomib 63 dexrazoxane 63 colorectal carcinoma 63 neurologic progression 63 temozolomide TMZ 63 patients undergoing CABG 63 eptifibatide 63 interferon alfa 2b 63 nucleoside analogues 63 allopurinol 63 fallopian tube cancers 63 Decitabine 63 ALA PDT 63 metastatic neuroendocrine tumors 63 DMARDs 63 CMV disease 63 milatuzumab 63 antiangiogenic agent 63 angiogenesis inhibitor 63 sorafenib 63 mutated KRAS 63 chemotherapies 63 sunitinib malate 63 micrometastases 63 parathyroidectomy 63 vincristine 63 LHRH agonists 63 metastatic colorectal 63 gastrointestinal stromal tumors GIST 63 cisplatin chemotherapy 63 distant metastases 63 VELCADE melphalan 63 XELOX 63 doxorubicin cyclophosphamide 63 chemotherapeutic drug 63 nadolol 63 goserelin 63 orthotopic 63 anthracyclines 63 Bevacizumab 63 endocrine therapies 63 biochemical relapse 63 cediranib 63 penetrating keratoplasty 63 unfractionated heparin 63 irbesartan 63 BCG refractory 63 IL 1ß 63 glycoprotein IIb IIIa inhibitors 63 breast carcinoma 63 Fluorouracil 63 mg kg dose 63 paclitaxel Taxol 63 Cremophor 63 hepatic resection 63 placebo dexamethasone 62 intravenous bisphosphonates 62 gemcitabine chemotherapy 62 PREZISTA r 62 lanreotide 62 Sorafenib 62 Xanafide 62 colorectal adenoma 62 surgical revascularization 62 taxanes 62 Bezielle 62 PCa 62 Erlotinib 62 5-fluorouracil/leucovorin 62 biologic therapy 62 imetelstat 62 Gefitinib 62 IFN alpha 62 relapsed SCLC 62 antiangiogenic 62 colectomy 62 rFVIIa 62 Vascugel 62 revascularization 62 Platinol 62 relapsed MM 62 gastrointestinal stromal tumors 62 paricalcitol 62 CTEPH 62 care regimens CCR 62 esophagectomy 62 caspofungin 62 ritonavir boosted 62 prospectively defined 62 relapsed CLL 62 fludarabine 62 Ceplene/IL-2 62 immunohistochemical 62 KRAS wild 62 6 mercaptopurine 62 pelvic lymphadenectomy 62 debulking surgery 62 palliation 62 dalteparin 62 FUSILEV enhances 62 adrenalectomy 62 tumor recurrence 62 adjuvant radiation 62 cell lymphoma CTCL 62 perioperative complications 62 CANCIDAS 62 prostate cancer HRPC 62 luteinizing hormone releasing 62 flutamide 62 Pemetrexed 62 KRAS mutations occur 62 Dasatinib 62 intratumoral 62 alteplase 62 allogeneic hematopoietic stem cell 62 abacavir lamivudine 62 cabazitaxel 62 nephrotoxicity 62 Radiofrequency Ablation RFA 62 TKIs 62 Cyclophosphamide 62 GW# [003] 62 oncologic outcomes 62 adjuvant radiotherapy 62 CIMZIA ™ 62 CYT# potent vascular disrupting 62 Azacitidine 62 malignant pleural mesothelioma 62 rituximab 62 imipenem 62 IFN alfa 62 follicular NHL 62 Platinol ® cisplatin 62 inotropic 62 neostigmine 62 eplerenone 62 VATS lobectomy 62 TNF inhibitor 62 direct thrombin inhibitors 62 biliary tract cancer 62 cyclophosphamide 62 haematopoietic 62 VIDAZA 62 TAXUS Express Stent 62 paclitaxel chemotherapy 62 antiangiogenic therapy 62 chemotherapy gemcitabine 62 antiandrogen 62 interferon ribavirin 62 dyskinetic 62 oral allopurinol 62 metastatic malignant melanoma 62 plus dexamethasone 62 pamidronate 62 GP IIb IIIa inhibitors 62 epithelial tumors 62 ErbB2 positive 62 Mitoxantrone 62 PSA nadir 62 TEVAR 62 endoscopic resection 62 receiving VICTRELIS 62 SCCHN 62 angiotensin receptor blocker ARB 62 VEGF receptor 62 relapsed multiple myeloma 62 thyroglobulin 62 ropivacaine 62 tolvaptan 62 EGF receptor 62 acute leukemias 62 vWF 62 Cetuximab 62 depsipeptide 62 Traficet EN 62 locoregional disease 62 Neoadjuvant 62 pomalidomide 62 teriflunomide 62 Flu Cy 62 antitumor effect 62 Peg IFN 62 peginterferon 62 EGFR tyrosine kinase inhibitors 62 adjuvant tamoxifen 62 erlotinib 62 recurrent NSCLC 62 tenecteplase 62 mcg albinterferon alfa 2b 61 radiotherapy RT 61 mapatumumab 61 everolimus eluting stents 61 paclitaxel cisplatin 61 etanercept 61 HER2 overexpression 61 axillary lymph node dissection 61 erythropoietic 61 trans retinoic acid ATRA 61 trastuzumab Herceptin ® 61 inhibitor RG# 61 RALP 61 sirolimus eluting stents 61 contralateral breast 61 sirolimus 61 liver metastasis 61 gastroesophageal junction 61 cilostazol 61 coronary intervention 61 thyroidectomy 61 dosage regimens 61 PegIFN RBV 61 chemotherapeutic agent 61 cinacalcet 61 cancer mCRC 61 intestinal metaplasia 61 unfractionated heparin UFH 61 LVEF 61 intraperitoneal chemotherapy 61 lipid lowering agents 61 Capecitabine 61 surgical debulking 61 submandibular gland 61 imatinib resistant 61 pegylated interferon alfa 2b 61 TTF Therapy 61 adenoma recurrence 61 BEACOPP 61 pegylated interferon alfa 61 Pegylated Interferon 61 retroperitoneal 61 Everolimus 61 calcineurin inhibitors 61 deferoxamine 61 biochemical recurrence 61 docetaxel Taxotere 61 FOLPI 61 HSP# inhibitor 61 Navelbine 61 EFAPROXYN 61 renal transplantation 61 imatinib mesylate 61 elective PCI 61 HBeAg seroconversion 61 tumor resection 61 TNFa 61 urothelial carcinoma 61 gastrointestinal stromal tumor GIST 61 Interferon alfa 61 hepatocellular carcinoma HCC 61 myeloablative 61 bivalirudin 61 FluCAM 61 transcranial Doppler ultrasound 61 somatostatin analog 61 Natalizumab 61 anti leukemic 61 stenting 61 tamsulosin 61 HDACi 61 partial remissions 61 RF ablation 61 crossclamp 61 Paraplatin ® 61 μmol L 61 Gleevec resistant 61 histological subtype 61 ertapenem 61 pain palliation 61 lactulose 61 incisional 61 coronary stenting 61 Imatinib 61 lanthanum carbonate 61 vasodilatory 61 median PFS 61 ketorolac 61 mCRC patients 61 low dose cytarabine 61 Hycamtin ® 61 LHRH receptor positive 61 intravesical instillation 61 drug zotarolimus 61 T2DM 61 anthracycline taxane 61 clinically localized prostate 61 tipranavir 61 dasatinib Sprycel 61 androgen ablation 61 CYPHER Stent 61 melphalan 61 rt PA 61 nucleoside analog 61 urography 61 Lenalidomide 61 immunosuppressive regimen 61 MabCampath 61 verteporfin 61 salpingo oophorectomy 61 relapsed refractory 61 5 FU leucovorin 61 CLL SLL 61 pyridostigmine 61 platelet inhibitor 61 posaconazole 61 chemotherapeutics 61 esomeprazole 61 autologous transplants 61 dose clopidogrel 61 orchidectomy 61 chemotherapy regimen 61 gastrectomy 61 interferon IFN 61 active comparator 61 dacarbazine DTIC 61 heavily pretreated 61 stent implantation 61 immunosuppressive agents 61 preoperative radiotherapy 61 multikinase inhibitor 61 pulmonary metastases 61 PSADT 61 antithrombotic 61 photocoagulation 61 prostate adenocarcinoma 61 anti androgen 61 Taxus Stent 61 antihypertensive therapy 61 hematologic toxicity 61 metastatic CRC 61 reintervention 61 coronary revascularization 61 tumor xenograft models 61 tiuxetan 61 endarterectomy 61 isoproterenol 61 brain metastases 61 immunohistochemical staining 61 oral rivaroxaban 61 methotrexate therapy 61 ULORIC 61 Kaplan Meier analysis 61 peg interferon 61 epirubicin cyclophosphamide 61 Epirubicin 61 trastuzumab Herceptin 61 pimecrolimus 61 cis retinoic acid 61 F FDG PET 61 reteplase 61 untreated multiple myeloma 61 FOLFIRINOX 61 insulin glargine 61 invasive bladder 61 timolol 61 amphotericin B 61 proteasome inhibitor bortezomib 61 comparator arm 61 Response Evaluation Criteria 61 pancreatectomy 61 primary patency 61 erlotinib Tarceva 61 metastatic lesions 61 mixed hyperlipidemia 61 transgene expression 61 cranial irradiation 61 nonmelanoma skin cancers 61 leucovorin 61 mTOR inhibitor 61 Pegasys ® 61 metaplasia 61 ganciclovir 61 fludarabine cyclophosphamide 61 extracranial 61 peptide BNP 61 percutaneous intervention 61 exemestane 61 mucinous 61 BAY #-# 61 Vidaza azacitidine 61 xenograft tumors 60 interferon beta 1a 60 intravenous cyclophosphamide 60 panobinostat 60 nephron sparing surgery 60 radioembolization 60 FK# 60 sirolimus stent 60 chemotherapeutic 60 vandetanib 60 Folfox 60 adjuvant therapies 60 lipid lowering drugs 60 antiandrogens 60 Cystectomy 60 left ventricular dysfunction 60 PI3K inhibitor 60 familial amyloidotic polyneuropathy FAP 60 distant metastasis 60 plus gemcitabine 60 recombinant tissue plasminogen 60 zalutumumab 60 iniparib 60 relapsing multiple sclerosis 60 Amrubicin 60 complete cytogenetic response 60 fluvastatin 60 candesartan cilexetil 60 prostate cancer CRPC 60 peginterferon alfa 2a 60 oral anticoagulation 60 paclitaxel Taxol R 60 bevacizumab Avastin R 60 cyclosporin 60 Vidaza ® 60 nonmetastatic 60 Myelodysplastic Syndrome MDS 60 TORISEL 60 Carboplatin 60 endovascular repair 60 overlapping toxicities 60 operable breast cancer 60 papillary renal cell carcinoma 60 4mg/kg 60 H. pylori eradication 60 Omacetaxine mepesuccinate 60 rFSH 60 ribavirin Copegus ® 60 active moiety 60 ELACYT 60 saline placebo 60 transplantation HSCT 60 neovascularization 60 olmesartan 60 anastrozole 60 infarct size 60 darunavir ritonavir 60 lung metastasis 60 SLNB 60 myocardial reperfusion 60 situ CIS 60 Elitek 60 telaprevir dosed 60 Herceptin trastuzumab 60 CD3 monoclonal antibody 60 intravenously administered 60 aprepitant 60 olaparib 60 voriconazole 60 severe neutropenia 60 TNF Tumor Necrosis Factor 60 administered subcutaneously 60 hepatocellular carcinoma 60 rFVIII 60 teriparatide 60 myocardial ischemia 60 FOLFOX6 60 IOP lowering 60 lymph node metastases 60 antihypertensive agents 60 glomerular filtration 60 LY# [003] 60 TNF α 60 comparator PI r 60 tacrolimus ointment 60 protamine 60 non squamous NSCLC 60 fibrinolytic therapy 60 intracoronary 60 lenalidomide Revlimid R 60 Taxotere ® 60 lapatinib Tykerb 60 nicardipine 60 Intravesical 60 nonrandomized 60 urothelial cancer 60 doxorubicin HCl liposome injection 60 levosimendan 60 cytotoxic agents 60 surrogate endpoint 60 Cloretazine 60 SCIg 60 complement inhibitor eculizumab 60 revascularization procedures 60 microtubule targeting 60 reinfarction 60 CABG 60 zoledronate 60 carotid artery stenting 60 cilengitide 60 Hepatocellular Carcinoma HCC 60 lopinavir r 60 methotrexate monotherapy 60 noninferiority 60 repigmentation 60 micafungin 60 uric acid lowering 60 cytotoxicity 60 EGFR receptor 60 infusional 5-FU/LV 60 Accelerated Partial Breast Irradiation 60 transplant ASCT 60 glatiramer acetate 60 bone metastasis 60 evaluable 60 infliximab 60 kidney allograft 60 Catheter ablation 60 ara C 60 castrate resistant 60 transthoracic 60 endometrial carcinoma 60 irinotecan doxorubicin oxaliplatin paclitaxel 60 Fulvestrant 60 laparoscopic cholecystectomy 60 nodal metastases 60 cytotoxic 60 mediastinoscopy 60 invasive coronary angiography 60 pT2 60 aspirin clopidogrel 60 Imprime PGG 60 micrometastasis 60 catheter angiography 60 oral clodronate 60 TURBT 60 contrast induced nephropathy 60 Ranolazine 60 Vidofludimus 60 HER2 receptor 60 plus prednisone 60 Combination therapy 60 Rituximab 60 Thal Dex 60 Fas ligand 60 remission induction 60 FIRMAGON 60 Oxaliplatin 60 Interferon beta 60 EGFR inhibitors 60 NSTE ACS 60 Dacogen decitabine 60 Xcytrin 60 HGPIN 60 relapsed refractory multiple myeloma 60 pentamidine 60 isoenzyme 60 grade gliomas 60 bupivacaine 60 antiarrhythmic drug 60 occlusive disease 60 romiplostim 60 cyclophosphamide Cytoxan 60 alkylating 60 epithelial ovarian 60 tirofiban 60 stent restenosis 60 Vaprisol 60 Platinol ® 60 Percutaneous Transluminal Coronary Angioplasty 60 corticosteroid therapy 60 metastatic gastric 60 alfa 2a 60 ximelagatran 60 NRTIs 60 inducible nitric oxide synthase 60 primary percutaneous coronary 60 stage IIIb IV 60 talabostat 60 AGILECT R 60 CorVue ™ 60 cholecystectomy 60 antiarrhythmic 60 INCB# [003] 60 alpha blocker 60 carotid artery stenting CAS 60 Surgical excision 60 rHuPH# 60 functional mitral regurgitation 60 ZACTIMA 60 chemotherapy regimens 60 Trabectedin 60 CLL cells 60 abacavir Ziagen 60 conventional angiography 60 anti angiogenic agents 60 itraconazole 60 ibandronate 60 differentiated thyroid 60 gadobutrol 60 carcinoid tumors 60 thiazide diuretic 60 assessing T DM1 60 Pegylated Liposomal Doxorubicin 60 Radical prostatectomy 60 HER2 negative 60 total thyroidectomy 60 ß blockers 60 angioplasty stenting 60 celecoxib 60 SHPT 60 PEGylated anti 60 pegylated interferon alfa 2a 60 glargine 60 viral kinetics 60 ARB telmisartan 60 pharmacokinetic interactions 60 colesevelam HCl 60 thalidomide dexamethasone 60 LHRH 60 anakinra 60 advanced unresectable 60 HRPC 60 bezafibrate 60 TKI therapy 60 intra arterial chemotherapy 60 Chemophase 60 intravesical infusion therapy 60 carvedilol 60 neoplastic cells 59 histologies 59 mCi kg 59 endocrine therapy 59 prostate cancer CaP 59 Estrogen Receptor 59 complete remissions 59 Fenretinide 59 dipyridamole 59 salmeterol fluticasone 59 EGFR HER2 59 bronchogenic carcinoma 59 neoplastic 59 ixabepilone 59 #Gy 59 IGF 1R 59 tumor necrosis 59 dacarbazine chemotherapy 59 axitinib 59 echinocandin 59 hepatectomy 59 ACE inhibitor ramipril 59 nodal dissection 59 KRAS mutant tumors 59 intraperitoneal injection 59 NRTI 59 explants 59 PD LID 59 metastatic tumors 59 HIPEC 59 Copegus ribavirin 59 lupus nephritis 59 PEGylated Fab fragment 59 sustained virological response 59 cytostatic 59 factor Xa 59 chemo radiotherapy 59 thrombolytics 59 STRIDE PD 59 anthracycline 59 Peginterferon 59 vinca alkaloids 59 irinotecan 59 ureteroscopy 59 strontium ranelate 59 #F FDG 59 cholangiocarcinoma 59 axillary node dissection 59 Doxil 59 T#I [002] 59 TAXOTERE R 59 intravenous dosing 59 prostate cancer AIPC 59 nonoperative treatment 59 ablative therapy 59 node dissection 59 nondiabetic patients 59 prednisone prednisolone 59 coadministration 59 dasatinib Sprycel ® 59 endothelial keratoplasty 59 antidiabetic 59 antimicrobial prophylaxis 59 histone deacetylase HDAC inhibitor 59 interferon alpha 59 cangrelor 59 PKC# 59 undetectable HBV DNA 59 carotid endarterectomy 59 N acetylcysteine 59 adenoma 59 molecularly targeted 59 thymectomy 59 PARP inhibitor 59 ePTFE graft 59 galiximab 59 efalizumab 59 liver histology 59 cisplatin vinorelbine 59 intratumoral injection 59 evaluating tivozanib 59 Etoposide 59 TLIF 59 squamous 59 TYKERB 59 ELOXATIN 59 Protelos 59 pegfilgrastim 59 lapatinib 59 LV dysfunction 59 tigecycline 59 lesional 59 malignant ascites 59 Gemzar ® 59 insulin sensitizing 59 axillary dissection 59 VA# [002] 59 timepoints 59 acute GvHD 59 LVRS 59 chemotherapy FOLFOX 59 angiotensin II receptor blocker 59 microwave hyperthermia 59 Advanced Renal Cell 59 calcineurin inhibitor 59 pro angiogenic 59 varices 59 graft patency 59 metformin sulfonylurea 59 vitro cytotoxicity 59 tyrosine kinase inhibitors TKIs 59 Subgroup analysis 59 cerebral vasospasm 59 Pertuzumab 59 recurrent glioblastoma 59 HuLuc# 59 percutaneous transluminal coronary angioplasty 59 CR nPR 59 EGFR TKI 59 Hydroxyurea 59 recurrent ovarian cancer 59 seliciclib 59 aortic root replacement 59 percutaneous vertebroplasty 59 bronchial thermoplasty 59 Alocrest 59 PDGFR 59 achieved ACR# 59 Vectibix monotherapy 59 PDGF receptor 59 epoetin alfa 59 somatostatin analogues 59 GAMMAGARD 59 hepatoma 59 Pioglitazone